COVID-19 antiviral treatments will no longer be free under the prescription waiver fee HEAL-COVID and STIMULATE-ICP clinical trial platforms.

The Department of Health introduced the change from March 31 and has removed references to the COVID-19 antiviral treatments throughout the documentation.